These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38993218)

  • 1. Prognostic Role of mRNA-Expression of Aquaporins (AQP) 3, 4, 7 and 9 in Stage pT1 Non-Muscle-Invasive Bladder Cancer.
    Reiß J; Kälble S; Bründl J; Rosenhammer B; Gierth M; Weber F; Eckstein M; Wirtz RM; Denzinger S; Burger M; Otto W; Breyer J
    Bladder Cancer; 2021; 7(1):71-78. PubMed ID: 38993218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer.
    Otto W; Rubenwolf PC; Burger M; Fritsche HM; Rößler W; May M; Hartmann A; Hofstädter F; Wieland WF; Denzinger S
    BMC Cancer; 2012 Oct; 12():459. PubMed ID: 23043286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients.
    Breyer J; Wirtz RM; Otto W; Erben P; Worst TS; Stoehr R; Eckstein M; Denzinger S; Burger M; Hartmann A
    Cancer Immunol Immunother; 2018 Mar; 67(3):403-412. PubMed ID: 29150702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer.
    Breyer J; Wirtz RM; Erben P; Rinaldetti S; Worst TS; Stoehr R; Eckstein M; Sikic D; Denzinger S; Burger M; Hartmann A; Otto W
    BJU Int; 2019 Jan; 123(1):187-196. PubMed ID: 30120861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.
    Breyer J; Wirtz RM; Otto W; Erben P; Kriegmair MC; Stoehr R; Eckstein M; Eidt S; Denzinger S; Burger M; Hartmann A;
    Virchows Arch; 2017 Mar; 470(3):267-274. PubMed ID: 28074276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of AQP3 protein expression is associated with worse progression-free and cancer-specific survival in patients with muscle-invasive bladder cancer.
    Rubenwolf P; Thomas C; Denzinger S; Hartmann A; Burger M; Georgopoulos NT; Otto W
    World J Urol; 2015 Dec; 33(12):1959-64. PubMed ID: 25939538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ.
    Breyer J; Otto W; Wirtz RM; Wullich B; Keck B; Erben P; Kriegmair MC; Stoehr R; Eckstein M; Laible M; Schlombs K; Eidt S; Denzinger S; Burger M; Hartmann A;
    Urol Int; 2017; 98(3):282-289. PubMed ID: 27992871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage.
    Rubenwolf PC; Otto W; Denzinger S; Hofstädter F; Wieland W; Georgopoulos NT
    World J Urol; 2014 Aug; 32(4):991-7. PubMed ID: 24022233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant prognostic values of aquaporin mRNA expression in breast cancer.
    Zhu L; Ma N; Wang B; Wang L; Zhou C; Yan Y; He J; Ren Y
    Cancer Manag Res; 2019; 11():1503-1515. PubMed ID: 30863160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies.
    Breyer J; Wirtz RM; Otto W; Laible M; Schlombs K; Erben P; Kriegmair MC; Stoehr R; Eidt S; Denzinger S; Burger M; Hartmann A
    Oncotarget; 2017 Sep; 8(40):67684-67695. PubMed ID: 28978063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of aquaporins 3 in low grade risk of recurrence primary bladder cancer.
    Ticonosco M; Assumma S; Iseppi A; Benedetti M; Sarchi L; Ferrari R; Calcagnile T; Rocco B; Sighinolfi MC; Alriyalat S; Reggiani Bonetti L; Migaldi M; Micali S
    Urologia; 2021 Aug; 88(3):190-193. PubMed ID: 33612088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC).
    Spachmann PJ; Azzolina V; Weber F; Evert M; Eckstein M; Denzinger S; Burger M; Otto W; Breyer J
    Pathol Oncol Res; 2020 Jul; 26(3):1625-1632. PubMed ID: 31506803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer.
    Eckstein M; Kimmel C; Bruendl J; Weber F; Denzinger S; Gierth M; Burger M; Hartmann A; Otto W; Breyer J
    Sci Rep; 2021 Sep; 11(1):17981. PubMed ID: 34504238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.
    Sikic D; Breyer J; Hartmann A; Burger M; Erben P; Denzinger S; Eckstein M; Stöhr R; Wach S; Wullich B; Keck B; Wirtz RM; Otto W
    Transl Oncol; 2017 Jun; 10(3):340-345. PubMed ID: 28342317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of aquaporin expression in liver with a focus on hepatocytes.
    Gregoire F; Lucidi V; Zerrad-Saadi A; Virreira M; Bolaky N; Delforge V; Lemmers A; Donckier V; Devière J; Demetter P; Perret J; Delporte C
    Histochem Cell Biol; 2015 Oct; 144(4):347-63. PubMed ID: 26126651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).
    Breyer J; Wirtz RM; Laible M; Schlombs K; Erben P; Kriegmair MC; Stoehr R; Eidt S; Denzinger S; Burger M; Hartmann A; Otto W
    Virchows Arch; 2016 Nov; 469(5):547-552. PubMed ID: 27514658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study.
    van Rhijn BWG; Hentschel AE; Bründl J; Compérat EM; Hernández V; Čapoun O; Bruins HM; Cohen D; Rouprêt M; Shariat SF; Mostafid AH; Zigeuner R; Dominguez-Escrig JL; Burger M; Soukup V; Gontero P; Palou J; van der Kwast TH; Babjuk M; Sylvester RJ;
    Eur Urol Oncol; 2021 Apr; 4(2):182-191. PubMed ID: 33423944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy.
    De Berardinis E; Busetto GM; Antonini G; Giovannone R; Gentile V
    Int Urol Nephrol; 2011 Dec; 43(4):1047-57. PubMed ID: 21442469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer.
    Rouanne M; Betari R; Radulescu C; Goubar A; Signolle N; Neuzillet Y; Allory Y; Marabelle A; Adam J; Lebret T
    Eur J Cancer; 2019 Feb; 108():111-119. PubMed ID: 30654296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.